Who Paid My Doc
FebriDx DISRUPT
ClinicalTrials.gov NCT02018198
Research payments
$366,683
Through program year 2022, $366,683 in research payments was reported against FebriDx DISRUPT, across 33 payments, paid by Rapid Pathogen Screening, Inc..
- Paid by
- Rapid Pathogen Screening, Inc.
- ClinicalTrials.gov
- NCT02018198
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $13,500 | 8 |
| 2021 | Research | $353,183 | 25 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jeffrey Harris Greenville, SC Named on 9 payments
- Jorge Diaz Hialeah, FL Named on 5 payments
- Scott Dobson Greenville, SC Named on 2 payments
- Rupal Trivedi Saint Louis, MO Named on 2 payments
- Teena Hughes Tampa, FL Named on 2 payments
- Marc Mickiewicz Nashville, TN Named on 2 payments
- Stephan Sharp Nashville, TN Named on 1 payment
- Eliot Godofsky Bradenton, FL Named on 1 payment
- Natasha Ballard Chattanooga, TN Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.